On behalf of the Organizing Committee, it is my great pleasure to invite you to participate in the International Academy of Cardiology, Annual Scientific Sessions 2017, 22nd WORLD CONGRESS ON HEART DISEASE, Vancouver, BC, Canada, July 14-16, 2017.
The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.
Plans for this CME meeting are progressing extremely well. Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.
Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials. We hope that you will participate in this Congress and submit for presentation your most recent scientific work in the rapidly evolving field of cardiovascular disease.
Your interaction with your colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding. We look forward to your active participation in the 22nd WORLD CONGRESS ON HEART DISEASE and to welcoming you to the beautiful city of Vancouver in July.
MOLECULAR CARDIOLOGY, BASIC RESEARCH
Apoptosis in vascular and cardiac remodeling
Oxidative stress and anti-oxidant therapy
Genetic determinants of coronary heart disease
Genetic studies in cardiomyopathy
Gene transfer and therapy
The pathogenesis of atherosclerosis
Extracellular matrix and atherosclerosis
Immunological principles in coronary artery disease
Growth control and cytokines in vascular cells
Neointimal hyperplasia and vascular injury
Pharmacologic modulation of vascular-endothelial function
DIAGNOSTIC METHODS
Biochemical markers of acute ischemia
Transesophageal echocardiography
Pharmacologic stress testing - echocardiography
Echocardiography, three-dimensional reconstruction
Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability
PET - new insights into myocardial metabolism
Applications of cardiac magnetic resonance imaging
CT and coronary calcification
Percutaneous coronary angioscopy
Intravascular ultrasound imaging
Intracoronary flow, doppler measurements
CORONARY ARTERY DISEASE
The plaque and acute coronary syndromes
Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
Acute myocardial infarction: thrombolysis and reperfusion
Angioplasty therapy for acute myocardial infarction
Stents: new devices/optimal application/multiple stents
Antithrombotic and antiplatelet adjunctive therapy for PTCA
Blockade of tissue proliferation after coronary interventions
Restenosis - use of ionizing radiation
Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
Left ventricular remodeling after myocardial infarction
Assessment of prognosis, post acute myocardial infarction
Secondary prevention, risk stratification
Cardiac rehabilitation as secondary prevention: is it worth the effort?
Can the progress of atherosclerosis be halted?
Modification of lipoproteins and coronary disease
Hypertension, new therapeutic approaches
Diabetes mellitus, obesity, insulin and atherosclerosis
Mental stress: its effect on cardiovascular health
Primary prevention of coronary artery disease in the healthy adult
Hormone therapy in postmenopausal women: does it alter coronary risk?
Prevention in children
HEART FAILURE
Neurohumoral, immunologic and cytokine aspects of heart failure
Nitric oxide and nitric oxide synthase in heart failure
Myocyte and receptor abnormalities in heart failure
Natriuretic peptides, endothelin: role in heart failure
Inflammatory mediators and heart failure
Dilated cardiomyopathy: various etiologies
Ischemic cardiomyopathy
Left ventricular hypertrophy and hypertrophic cardiomyopathy
Role of the pericardium, pericarditis and restrictive cardiomyopathy
Pathophysiologic and prognostic insights in valvular heart disease
Pulmonary circulation aspects, pulmonary hypertension
Predictors and markers of heart failure outcome
Exercise physiology in heart failure
Renal aspects - diuretics
Digoxin and other new inotropic agents in heart failure
ACE inhibitors and Angiotensin-ll receptor blockers
Beta-blockers and beta-adrenergic receptors in heart failure
Calcium channel blockers and promoters in heart failure
Cardiac pacing strategies in heart failure
ARRHYTHMIAS
Arrhythmias and antiarrhythmic drug therapy
Atrial flutter/fibrillation - electrophysiologic concepts and clinical aspects
Management of cardiac arrhythmias pediatric population
Heart rate variability and prognostic implications
QT prolongation/dispersion: pathophysiology and prognostic implications
Sudden death
Electrophysiologic techniques of mapping and radiofrequency ablation
Advances in internal defibrillation and implantable antiarrhythmic devices
Cardiac Pacing
CARDIAC SURGERY
Advances in congenital heart disease
Angioplasty or surgery for multivessel coronary artery disease
New approaches to surgical revascularization: Minimally invasive surgery, TMLR
Therapeutic and physiologic issues surrounding heart valve surgery
Mechanical support left ventricular assist devices
Surgery for LV dysfunction
Cardiac transplantation
MISCELLANEOUS
Practice guidelines, cost containment
Computers in cardiology
07月14日
2017
07月16日
2017
初稿截稿日期
注册截止日期
留言